CHARACTERISATION OF CARDIOVASCULAR LESIONS IN PATIENTS WITH COMORBID CONDITIONS

Authors

  • Rakhimova G. P. Tashkent Medical Academy
  • Jabbarov O. O. Tashkent Medical Academy
  • Alyavi A. L. Tashkent Medical Academy
  • Tursunova L. D. Tashkent Medical Academy
  • Nazarova N. O. Tashkent Medical Academy
  • Maksudova M. H. Tashkent Medical Academy
  • Saidaliev R. S. Tashkent Medical Academy
  • Nadirova Y. I. Tashkent Medical Academy

Abstract

Comorbidity is the presence of an additional clinical picture that already exists or can appear independently, in addition to the current disease, and is always different from it. It is known that comorbidity in modern conditions is considered as one of the conditions for realisation of an unfavourable course of any acute and chronic disease.

References

1. Ступаков И. Н., Самородская И. В. Доказательная медицина и сердечно-сосудистые заболевания НЦССХ им. А. Н. Бакулева// Под ред. Бокерия Л. А. — М, 2006.

2. Morris N.J., Wang S.L., Stevens L.K. et al. Mortality and causes of death in the WHO Multinational Study of Vascular Disease in Diabetes // Diabetol. 2001. Vol. 44 (Suppl. 2). S. 1 4–21.

3. Карпов Ю. А., Сорокин Е. В. Первичная профилактика сердечно-сосудистых заболеваний: новые ориентиры // Русский медицинский журнал. — 2002. — Т. 10. — №19.

4. Paulus W. J., Tschope C., SandersonF J. E. et al. How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology. Eur. Heart J. 2007; 28: 2539— 2550.

5. Жаббаров, О. О., Джуманиязова, З. Ф., & Рахимова, Г. П. (2022). Клинико-патогенетические аспекты кардиоренального синдрома.

6. Lang R. M., Bierig M., Devereaux R. B. et al. Recommendations for chamber quantifi cation. J. Am. Soc. Echocardiogr. 2005; 18: 1440—1463.

7. Рахимова, Г. П. (2022). Особенности почечной гемодинамике при кардиоренального синдрома (Doctoral dissertation, Ташкент).

Downloads

Published

2024-11-26

How to Cite

G. P., R., O. O., J., A. L., A., L. D., T., N. O., N., M. H., M., … Y. I., N. (2024). CHARACTERISATION OF CARDIOVASCULAR LESIONS IN PATIENTS WITH COMORBID CONDITIONS. EUROPEAN JOURNAL OF MODERN MEDICINE AND PRACTICE, 4(11), 660–662. Retrieved from http://inovatus.es/index.php/ejmmp/article/view/4586